Heart Attack Patients' Lipoprotein Levels Shift Over Time

The FRENCHIE-Lp(a) study looked at adults hospitalized for acute heart attack across 21 centers. Researchers wanted to see how lipoprotein(a) levels change after the initial hospital stay and find a practical way to measure it. They focused on patients aged 61 on average, with about one in five being women. This group gave the team a solid base for tracking changes over time.

At the start of care, the average lipoprotein(a) was 13 mg/dL. This number stayed roughly the same over the follow-up period, with no real change in the median. However, while the actual value didn't shift much, many patients actually moved between different categories of risk over time. About two-thirds of them stayed in the same group, but one-third switched categories. This movement shows that the disease process can alter these measurements even when the baseline looks stable.

When they compared patients who left the hospital with low levels (37 mg/dL or less) to those with higher levels, the difference was clear. Only 0.97% of the low-risk group eventually had levels above 70 mg/dL at follow-up, compared to 39.9% of the high-risk group. This shows that the initial discharge measurement is a strong predictor. To make this even more reliable, the team proposed a two-step approach: measure at discharge and then test again for those with higher levels. This method keeps misclassification below 1%.

This strategy is being tested in a clinical trial called NCT04050956. The study aims to help doctors decide who might need treatment based on these lipoprotein(a) measurements. It's a practical way to use a blood test that could guide future therapies for heart attack patients. By understanding how these levels evolve, medical teams can make smarter choices about when to intervene.